Sophion Bioscience Announces Adoption Of Qube384 Automated Patch Clamp System By Charles River Laboratories
Sophion, part of Biolin Scientific today announced that Charles River Laboratories has acquired a Qube384 Automated Patch Clamp (APC) System. Charles River’s expanded ion channel drug discovery work highlights their continued dedication to high-throughput screening as a mechanism for studying disorders in a variety of therapeutic indications.
Sophion Vice President Thais Johansen states “We have partnered closely with Charles River for many years, having several Sophion QPatch instruments as a key offering for ion channel safety and characterization. We will now look forward to the extension of this partnership with Qube384 for high-throughput screening”.
Qube384 is a giga-seal based automated patch clamp instrument that enables recording of small currents from the flow of ions through large integral membrane proteins called ion channels. Ion channel function covers a broad range of functionalities from the sensation and transmission of pain to the control of heart beat and learning and memory. The malfunction of ion channel behavior can lead to many type of diseases and ion channel modulators play an important role in treating and even curing these diseases.
About Sophion, part of Biolin Scientific
Sophion Bioscience, a leader in the automated patch clamp field, helps drug discovery companies make more and better drugs, faster. Sophion provide integrated solutions for automated patch clamping and the two product families QPatch and Qube provide high-quality patch clamp data on a truly industrial basis, focused on unattendedness and easy of use ensuring high lab efficiency and rapid turnaround time to result.
Biolin Scientific is a leading Nordic instrumentation company with roots in Sweden, Denmark and Finland. Our customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. Our precision instruments help discover better drugs faster, develop better solutions for energy and materials, and perform research at the frontiers of science and technology. Biolin Scientific provides products and services in more than 70 countries around the world.
www.biolinscientiic.com
Sophion Vice President Thais Johansen states “We have partnered closely with Charles River for many years, having several Sophion QPatch instruments as a key offering for ion channel safety and characterization. We will now look forward to the extension of this partnership with Qube384 for high-throughput screening”.
Qube384 is a giga-seal based automated patch clamp instrument that enables recording of small currents from the flow of ions through large integral membrane proteins called ion channels. Ion channel function covers a broad range of functionalities from the sensation and transmission of pain to the control of heart beat and learning and memory. The malfunction of ion channel behavior can lead to many type of diseases and ion channel modulators play an important role in treating and even curing these diseases.
About Sophion, part of Biolin Scientific
Sophion Bioscience, a leader in the automated patch clamp field, helps drug discovery companies make more and better drugs, faster. Sophion provide integrated solutions for automated patch clamping and the two product families QPatch and Qube provide high-quality patch clamp data on a truly industrial basis, focused on unattendedness and easy of use ensuring high lab efficiency and rapid turnaround time to result.
Biolin Scientific is a leading Nordic instrumentation company with roots in Sweden, Denmark and Finland. Our customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. Our precision instruments help discover better drugs faster, develop better solutions for energy and materials, and perform research at the frontiers of science and technology. Biolin Scientific provides products and services in more than 70 countries around the world.
www.biolinscientiic.com